Karyopharm Therapeutics Inc (KPTI) Actualités

Form DEF 14A - Other definitive proxy statements

Karyopharm Announces the Appointment of Brendan Strong as Senior Vice President of Investor Relations and Corporate Communications

Karyopharm Announces the Appointment of Brendan Strong as Senior Vice President of Investor Relations and...

Form PRE 14A - Other preliminary proxy statements

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Karyopharm Therapeutics Provides Endometrial Cancer Program Update

Karyopharm Therapeutics Provides Endometrial Cancer Program Update PR Newswire NEWTON, Mass., Dec. 3, 2024...

Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PR Newswire NEWTON...

Karyopharm to Participate at the Piper Sandler 36th Annual Healthcare Conference

Karyopharm to Participate at the Piper Sandler 36th Annual Healthcare Conference PR Newswire NEWTON, Mass...

Form 3 - Initial statement of beneficial ownership of securities

Form 8-K - Current report

Karyopharm Therapeutics Announces the Appointment of Chief Accounting Officer

Karyopharm Therapeutics Announces the Appointment of Chief Accounting Officer PR Newswire NEWTON, Mass., Nov...

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

Form S-8 - Securities to be offered to employees in employee benefit plans